Alabama STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alabama STEM News.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on September 17, 2025

September 17, 2025

ChowChow Cloud Announces Pricing of Initial Public Offering

GlobeNewswire

September 17, 2025

عدد مستخدمي منصة PartyPlatform الإماراتية يصل إلى 10,000 مستخدم، ما يُحدث تحولًا في قطاع تنظيم الفعاليات بالإمارات من خلال سوقٍ أكثر ذكاءً

GlobeNewswire

September 17, 2025

Fanspicy Announces Expanded Payment Solutions for Creators

GlobeNewswire

September 17, 2025

Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study

GlobeNewswire

September 17, 2025

Silicon Valley Certification Hub Records 30% QoQ Revenue Growth as Demand for AI Certification Accelerates

GlobeNewswire

September 17, 2025

Mawson Infrastructure Group Inc. Shares Corporate Update

GlobeNewswire

September 17, 2025

Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years

GlobeNewswire

September 17, 2025

Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation

GlobeNewswire

September 17, 2025

Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe

GlobeNewswire

September 17, 2025

Red Cat Holdings Announces Proposed Public Offering of Common Stock

GlobeNewswire

September 17, 2025

NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1

GlobeNewswire

September 17, 2025

NANOBIOTIX annonce de nouveaux résultats de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle en traitement de deuxième ligne ou plus chez des patients atteints de mélanome cutané résistant aux anti-PD-1

GlobeNewswire

September 17, 2025

Vor Bio Announces Oral Presentation of 48-Week China Phase 3 Generalized Myasthenia Gravis Clinical Study at AANEM

GlobeNewswire

September 17, 2025

Vaxart Appoints W. Mark Watson as Lead Independent Director

GlobeNewswire

September 17, 2025

Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update

GlobeNewswire

September 17, 2025

Aeluma Announces Proposed Public Offering of Common Stock

GlobeNewswire

September 17, 2025

Lloyds Banking Group estende la partnership strategica con Broadcom per accelerare la trasformazione digitale

GlobeNewswire

September 17, 2025

Lloyds Banking Group weitet strategische Partnerschaft mit Broadcom zur Beschleunigung der digitalen Transformation aus

GlobeNewswire

September 17, 2025

Lloyds Banking Group amplía su alianza estratégica con Broadcom para acelerar la transformación digital

GlobeNewswire

September 17, 2025

Lloyds Banking Group développe son partenariat stratégique avec Broadcom en vue d’accélérer la transformation numérique

GlobeNewswire